
    
      This study compares new oral Nicotine Replacement Therapy (NRT) products containing 2 and 4
      mg nicotine with NiQuitinâ„¢ lozenge 2 mg and 4 mg, after 12 hours of nicotine abstinence, with
      respect to nicotine pharmacokinetics, during 12 hours after start of administration. Single
      doses of treatment A, B, C, and D are given once in the morning during separate treatment
      visits scheduled in a crossover setting with randomized treatment sequences, also including a
      fifth treatment visit with either treatment E or F. The study will include 104 healthy
      smokers between the ages of 19 and 50 years, who have been smoking at least 10 cigarettes
      daily during at least one year preceding inclusion. The study will be performed at two sites
      with 52 subjects at each site. Subjects and study personnel will be aware of which treatment
      is administered at a given visit.
    
  